499 related articles for article (PubMed ID: 31666668)
1. Circulating biomarkers in patients with glioblastoma.
Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
[TBL] [Abstract][Full Text] [Related]
2. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Circulating Biomarkers of Brain Tumors.
Jelski W; Mroczko B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
[TBL] [Abstract][Full Text] [Related]
4. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
5. Emerging circulating biomarkers in glioblastoma: promises and challenges.
Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
[TBL] [Abstract][Full Text] [Related]
6. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA.
Pacia CP; Yuan J; Yue Y; Xu L; Nazeri A; Desai R; Gach HM; Wang X; Talcott MR; Chaudhuri AA; Dunn GP; Leuthardt EC; Chen H
Theranostics; 2022; 12(1):362-378. PubMed ID: 34987650
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
Yekula A; Muralidharan K; Rosh ZS; Youngkin AE; Kang KM; Balaj L; Carter BS
Adv Biosyst; 2020 Dec; 4(12):e2000029. PubMed ID: 32484293
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
9. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping.
Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G
Commun Biol; 2019; 2():315. PubMed ID: 31453379
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
Šamec N; Zottel A; Videtič Paska A; Jovčevska I
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979318
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy for brain tumors.
Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
13. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
Birkó Z; Nagy B; Klekner Á; Virga J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
[No Abstract] [Full Text] [Related]
14. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges of circulating biomarkers in neuroblastoma.
Trigg RM; Shaw JA; Turner SD
Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
Rackles E; Lopez PH; Falcon-Perez JM
Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
[TBL] [Abstract][Full Text] [Related]
17. Tumor-educated platelets.
In 't Veld SGJG; Wurdinger T
Blood; 2019 May; 133(22):2359-2364. PubMed ID: 30833413
[TBL] [Abstract][Full Text] [Related]
18. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
[TBL] [Abstract][Full Text] [Related]
19. The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy.
Garcia CM; Toms SA
World Neurosurg; 2020 Jun; 138():425-435. PubMed ID: 32251831
[TBL] [Abstract][Full Text] [Related]
20. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma.
Bauman MMJ; Bouchal SM; Monie DD; Aibaidula A; Singh R; Parney IF
Neurosurg Focus; 2022 Dec; 53(6):E14. PubMed ID: 36455271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
